Detalles de la búsqueda
1.
Biological features and outcome of diffuse large B-cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective 'Elderly Project' by the Fondazione Italiana Linfomi.
Br J Haematol
; 201(4): 653-662, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36733229
2.
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL).
Haematologica
; 108(4): 1083-1091, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36384247
3.
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi.
Hematol Oncol
; 41(1): 78-87, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36177902
4.
Diagnostic accuracy and safety of EUS-guided end-cutting fine-needle biopsy needles for tissue sampling of abdominal and mediastinal lymphadenopathies: a prospective multicenter series.
Gastrointest Endosc
; 98(2): 191-198, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36990125
5.
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial.
Br J Haematol
; 196(5): 1184-1193, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34951009
6.
Dose-adjusted EPOCH and rituximab for the treatment of double expressor and double-hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome.
Haematologica
; 107(5): 1153-1162, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34289655
7.
Risk-tailored treatment of splenic marginal zone lymphoma.
Anticancer Drugs
; 33(1): e36-e42, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34407041
8.
A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL).
Br J Haematol
; 193(2): 280-289, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33476434
9.
A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma.
Invest New Drugs
; 39(4): 1028-1035, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33523334
10.
Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi.
Ann Hematol
; 100(10): 2547-2556, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34327561
11.
Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice.
Oncologist
; 24(9): 1246-1252, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30940746
12.
Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network.
Hematol Oncol
; 37(2): 160-167, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30726562
13.
Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi.
Hematol Oncol
; 36(1): 68-75, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28524259
14.
Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
Lancet Oncol
; 18(8): 1076-1088, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28668386
15.
The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL).
Am J Hematol
; 90(6): 499-503, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25720750
16.
The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana Linfomi.
Am J Hematol
; 90(1): 56-61, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25327841
17.
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma.
Blood Adv
; 8(6): 1541-1549, 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38181782
18.
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial.
Blood Adv
; 7(14): 3764-3774, 2023 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37058477
19.
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma.
Blood Adv
; 7(15): 4160-4169, 2023 08 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37276080
20.
Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphoma.
Oncologist
; 17(6): 838-46, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22610154